Form 8-K - Current report:
SEC Accession No. 0001104659-25-070554
Filing Date
2025-07-25
Accepted
2025-07-25 08:10:40
Documents
18
Period of Report
2025-07-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516030d4_8k.htm   iXBRL 8-K 45187
2 EXHIBIT 5.1 tm2516030d4_ex5-1.htm EX-5.1 18119
3 EXHIBIT 10.1 tm2516030d4_ex10-1.htm EX-10.1 167051
4 EXHIBIT 10.2 tm2516030d4_ex10-2.htm EX-10.2 68476
5 EXHIBIT 99.1 tm2516030d4_ex99-1.htm EX-99.1 10384
9 GRAPHIC tm2516030d4_ex5-1img001.jpg GRAPHIC 9407
10 GRAPHIC tm2516030d4_ex99-1img001.jpg GRAPHIC 3619
  Complete submission text file 0001104659-25-070554.txt   564482

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA omer-20250724.xsd EX-101.SCH 3008
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20250724_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20250724_pre.xml EX-101.PRE 22354
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2516030d4_8k_htm.xml XML 3564
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 251148722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)